Laboratorios Silanes

NCT06863636

Phase 3Recruiting2024231 people7 Mar 2025clinicaltrials.gov

NCT06516094

Phase 3Completed2024192 people23 Jul 2024clinicaltrials.gov

NCT04943692

Phase 3Suspended2021500 people29 Jun 2021clinicaltrials.gov

NCT04895059

Phase 1Completed201736 people20 May 2021clinicaltrials.gov

NCT04882293

Phase 3Status unknown202278 people11 May 2021clinicaltrials.gov

NCT04841096

Phase 3Completed2023162 people12 Apr 2021clinicaltrials.gov

NCT02064881

Phase 2/3Status unknown201572 people17 Feb 2014clinicaltrials.gov

NCT02063802

Phase 2Status unknown2012120 people14 Feb 2014clinicaltrials.gov

NCT01437813

Phase 1Completed201124 people21 Sept 2011clinicaltrials.gov

NCT01437800

Phase 1Completed201124 people21 Sept 2011clinicaltrials.gov

NCT01429818

Phase 4Completed200716 people7 Sept 2011clinicaltrials.gov

NCT01386671

Phase 3Completed2014203 people1 Jul 2011clinicaltrials.gov

NCT00941382

Phase 3Status unknown200860 people17 Jul 2009clinicaltrials.gov

NCT00941239

Phase 1Completed200724 people17 Jul 2009clinicaltrials.gov

NCT00941161

Phase 4Completed200928 people17 Jul 2009clinicaltrials.gov

NCT00940472

Phase 2/3Completed200920 people16 Jul 2009clinicaltrials.gov